Review Article
Discovery of Antimalarial Drugs from Streptomycetes Metabolites Using a Metabolomic Approach
Table 1
List of antimalarial agent sources and their biological compounds.
| Actinobacteria | Compound | Testing approach | Reference |
| Streptomyces ochraceus and Streptomyces bottropensis | Trioxacarcins (Trioxacarcin A, B C D) | In vitro testing | [20] | Streptomyces sp. MSU-2110 | Coronamycins | In vitro testing | [21]
| Streptomyces NRRL 3052
| Munumbicins, E-4 and E-5 | In vitro testing | [22] | Streptomyces NRRL 30562 | Munumbicin D | In vitro testing | [23] | Streptomyces spectabilis BCC 4785 | Metacycloprodigiosin
| In vitro testing | [24] | Streptomyces sp. NRRL 30566 | Kakadumycin A
| In vitro testing | [25] | Streptomyces sp. SUK 10 | Gancidin-W | In vivo testing | [26] | Streptomyces albidoflavus | Antimycin A18 | In vitro testing | [27] | Streptomyces sp. CS,
| bafilomycin A1 | In vitro testing | [28] |
|
|